𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Non-invasive loco-regional therapy for hepatocellular carcinoma

✍ Scribed by Kyuichi Tanikawa

Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
386 KB
Volume
12
Category
Article
ISSN
8756-0437

No coin nor oath required. For personal study only.

✦ Synopsis

It is important to understand characteristic features of hepatocellular carcinoma (HCC) for its treatment, namely most HCC is associated with liver cirrhosis and is characterized by multicentric development. Percutaneous ethanol injection therapy (PEIT) has preferably been performed in Japan for small HCC, less than 30 mm in diameter, because no difference was found in the survival rate between patients treated by PEIT and surgical resection. One of the most important factors affecting the prognosis of PEIT was regular follow-up after treatment. For advanced nodular HCC, larger than 30 mm in diameter, transcatheter arterial chemo-embolization has usually been carried out. The prognosis of arterial chemotherapy for highly advanced HCC has been improved remarkably by using an implantable injection port. Additionally, the prevention of HCC recurrence after initial successful treatment has become an urgent problem.

πŸ“œ SIMILAR VOLUMES

Loco-regional treatment of hepatocellula
Loco-regional treatment of hepatocellular carcinoma
✍ Riccardo Lencioni πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 268 KB

Loco-regional treatments play a key role in the management of hepatocellular carcinoma (HCC). Image-guided tumor ablation is recommended in patients with early-stage HCC when surgical options are precluded. Radiofrequency ablation has shown superior anticancer effects and greater survival benefit wi

Determination of the optimal model for e
Determination of the optimal model for end-stage liver disease score in patients with small hepatocellular carcinoma undergoing loco-regional therapy
✍ Teh-Ia Huo; Jaw-Ching Wu; Han-Chieh Lin; Fa-Yauh Lee; Ming-Chih Hou; Yi-Hsiang H πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 100 KB πŸ‘ 1 views

The model for end-stage liver disease (MELD) has been a prevailing system to prioritize cirrhotic patients awaiting liver transplantation. An "exceptional" MELD score of 20 and 24 points is assigned for stage T1 and T2 patients with small hepatocellular carcinoma (HCC), respectively. However, this s

Predictors of microvascular invasion bef
Predictors of microvascular invasion before hepatectomy for hepatocellular carcinoma
✍ Masaki Kaibori; Morihiko Ishizaki; Kosuke Matsui; A-Hon Kwon πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 141 KB

## Abstract ## Background and Objectives Microvascular invasion (MVI) is difficult to detect before resection of hepatocellular carcinoma (HCC). ## Methods Clinicopathological and outcome data were retrospectively compared between 213 HCC patients with MVI and 221 patients without MVI who underw

Liver transplantation for non–hepatocell
Liver transplantation for non–hepatocellular carcinoma malignancies
✍ Gregory J. Gores; Julie K. Heimbach; Charles B. Rosen πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 139 KB

## Key Points 1. Hepatic epithelioid hemangioendothelioma is a rare disease with a variable natural history; current data support liver transplantation for unresectable disease. 2. Anti-vascular endothelial cell growth factor therapy may change the approach to hepatic epithelioid hemangioendotheli

A new approach to therapy for hepatocell
A new approach to therapy for hepatocellular carcinoma?
✍ Stephen A. Harrison; Adrian M. Di Bisceglie πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 59 KB

Objective: To assess the efficacy of 3-bromopyruvate (3-BrPA), a strong alkylating agent that inhibits hexokinase and mitochondrial oxidative phosphorylation, resulting in decreased cellular ATP production, on rabbit VX2 tumor cells. Methods: Adult New Zealand White rabbits were used for the study.